PRIMARY GENERALIZED TONIC-CLONIC SEIZURES
Clinical trials for PRIMARY GENERALIZED TONIC-CLONIC SEIZURES explained in plain language.
Never miss a new study
Get alerted when new PRIMARY GENERALIZED TONIC-CLONIC SEIZURES trials appear
Sign up with your email to follow new studies for PRIMARY GENERALIZED TONIC-CLONIC SEIZURES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New epilepsy drug XEN1101 tested for long-term seizure control
Disease control ENROLLING_BY_INVITATIONThis study tests the long-term safety and effectiveness of XEN1101 (azetukalner) in 880 adults with focal or tonic-clonic seizures. Participants who completed earlier studies will take XEN1101 capsules for up to 6 years. Researchers will track side effects and changes in monthly …
Matched conditions: PRIMARY GENERALIZED TONIC-CLONIC SEIZURES
Phase: PHASE3 • Sponsor: Xenon Pharmaceuticals Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Bridge program keeps seizure drug available for eligible patients
Disease control NO_LONGER_AVAILABLEThis program provides continued access to the seizure medication perampanel (Fycompa) for people who completed certain earlier studies and are still benefiting from the drug. It runs until the drug is commercially available in their country or no participants remain. Only those a…
Matched conditions: PRIMARY GENERALIZED TONIC-CLONIC SEIZURES
Sponsor: Eisai Inc. • Aim: Disease control
Last updated Jun 26, 2026 17:19 UTC